Phibro Animal Health Corporation
PAHC
$24.60
$0.100.41%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 31.79M | 19.32M | 17.41M | 2.42M | 13.16M |
Total Depreciation and Amortization | 40.96M | 37.54M | 34.88M | 34.74M | 34.10M |
Total Amortization of Deferred Charges | 3.14M | 2.83M | 2.58M | 2.48M | 2.45M |
Total Other Non-Cash Items | -2.20M | 962.00K | -2.83M | 14.85M | 10.61M |
Change in Net Operating Assets | 13.59M | -5.11M | 31.99M | 33.11M | 19.08M |
Cash from Operations | 87.28M | 55.54M | 84.02M | 87.59M | 79.40M |
Capital Expenditure | -38.22M | -40.21M | -43.35M | -41.24M | -39.06M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -291.88M | -290.78M | -3.28M | -3.28M | -3.28M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 39.34M | 59.61M | 10.86M | -3.67M | -7.03M |
Cash from Investing | -290.77M | -271.38M | -35.77M | -48.19M | -49.37M |
Total Debt Issued | 1.26B | 1.24B | 797.90M | 281.90M | 246.36M |
Total Debt Repaid | -1.00B | -950.25M | -802.48M | -266.57M | -238.31M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -19.45M | -19.44M | -19.44M | -19.44M | -19.44M |
Other Financing Activities | -15.56M | -13.45M | -13.24M | -2.66M | -3.49M |
Cash from Financing | 216.69M | 253.76M | -37.26M | -6.77M | -14.89M |
Foreign Exchange rate Adjustments | -3.07M | -3.81M | -2.30M | -3.30M | -2.16M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 10.13M | 34.10M | 8.68M | 29.33M | 12.99M |